These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 34298131)
21. Autophagy Function and Benefits of Autophagy Induction in Models of Spinocerebellar Ataxia Type 3. Watchon M; Luu L; Plenderleith SK; Yuan KC; Laird AS Cells; 2023 Mar; 12(6):. PubMed ID: 36980234 [TBL] [Abstract][Full Text] [Related]
22. The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases. Potapenko A; Davidson JM; Lee A; Laird AS Biochem J; 2024 Mar; 481(6):461-480. PubMed ID: 38497605 [TBL] [Abstract][Full Text] [Related]
23. Pathophysiological interplay between Pereira Sena P; Weber JJ; Watchon M; Robinson KJ; Wassouf Z; Hauser S; Helm J; Abeditashi M; Schmidt J; Hübener-Schmid J; Schöls L; Laird AS; Riess O; Schmidt T Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34785590 [TBL] [Abstract][Full Text] [Related]
24. Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis. Nóbrega C; Simões AT; Duarte-Neves J; Duarte S; Vasconcelos-Ferreira A; Cunha-Santos J; Pereira D; Santana M; Cavadas C; de Almeida LP Adv Exp Med Biol; 2018; 1049():349-367. PubMed ID: 29427113 [TBL] [Abstract][Full Text] [Related]
25. Deregulation of autophagy in postmortem brains of Machado-Joseph disease patients. Sittler A; Muriel MP; Marinello M; Brice A; den Dunnen W; Alves S Neuropathology; 2018 Apr; 38(2):113-124. PubMed ID: 29218765 [TBL] [Abstract][Full Text] [Related]
27. Sodium valproate increases activity of the sirtuin pathway resulting in beneficial effects for spinocerebellar ataxia-3 in vivo. Watchon M; Luu L; Robinson KJ; Yuan KC; De Luca A; Suddull HJ; Tym MC; Guillemin GJ; Cole NJ; Nicholson GA; Chung RS; Lee A; Laird AS Mol Brain; 2021 Aug; 14(1):128. PubMed ID: 34416891 [TBL] [Abstract][Full Text] [Related]
28. From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation. Da Silva JD; Teixeira-Castro A; Maciel P Neurotherapeutics; 2019 Oct; 16(4):1009-1031. PubMed ID: 31691128 [TBL] [Abstract][Full Text] [Related]
29. Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease. Costa Mdo C; Luna-Cancalon K; Fischer S; Ashraf NS; Ouyang M; Dharia RM; Martin-Fishman L; Yang Y; Shakkottai VG; Davidson BL; Rodríguez-Lebrón E; Paulson HL Mol Ther; 2013 Oct; 21(10):1898-908. PubMed ID: 23765441 [TBL] [Abstract][Full Text] [Related]
31. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD. Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414 [TBL] [Abstract][Full Text] [Related]
32. Compromised mitochondrial complex II in models of Machado-Joseph disease. Laço MN; Oliveira CR; Paulson HL; Rego AC Biochim Biophys Acta; 2012 Feb; 1822(2):139-49. PubMed ID: 22037589 [TBL] [Abstract][Full Text] [Related]
33. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease. Alves S; Régulier E; Nascimento-Ferreira I; Hassig R; Dufour N; Koeppen A; Carvalho AL; Simões S; de Lima MC; Brouillet E; Gould VC; Déglon N; de Almeida LP Hum Mol Genet; 2008 Jul; 17(14):2071-83. PubMed ID: 18385100 [TBL] [Abstract][Full Text] [Related]
34. Production of Spinocerebellar Ataxia Type 3 Model Mice by Intravenous Injection of AAV-PHP.B Vectors. Konno A; Shinohara Y; Hirai H Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000316 [TBL] [Abstract][Full Text] [Related]
36. Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease. Ferreira AF; Raposo M; Shaw ED; Ashraf NS; Medeiros F; Brilhante MF; Perkins M; Vasconcelos J; Kay T; Costa MDC; Lima M Cells; 2023 May; 12(10):. PubMed ID: 37408238 [TBL] [Abstract][Full Text] [Related]
37. Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia. Nóbrega C; Mendonça L; Marcelo A; Lamazière A; Tomé S; Despres G; Matos CA; Mechmet F; Langui D; den Dunnen W; de Almeida LP; Cartier N; Alves S Acta Neuropathol; 2019 Nov; 138(5):837-858. PubMed ID: 31197505 [TBL] [Abstract][Full Text] [Related]
38. Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice. Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Hirai H; Déglon N; de Almeida LP PLoS One; 2013; 8(1):e52396. PubMed ID: 23349684 [TBL] [Abstract][Full Text] [Related]
39. Machado Joseph disease severity is linked with gut microbiota alterations in transgenic mice. Gamage HKAH; Robinson KJ; Luu L; Paulsen IT; Laird AS Neurobiol Dis; 2023 Apr; 179():106051. PubMed ID: 36822548 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of FKH-2/FOXG1 is neuroprotective in a C. elegans model of Machado-Joseph disease. Fardghassemi Y; Parker JA Exp Neurol; 2021 Mar; 337():113544. PubMed ID: 33290777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]